SOLDOVIERI, Maria Virginia
 Distribuzione geografica
Continente #
NA - Nord America 2.315
EU - Europa 1.887
AS - Asia 382
AF - Africa 99
SA - Sud America 23
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 10
Totale 4.729
Nazione #
US - Stati Uniti d'America 2.291
IE - Irlanda 630
RU - Federazione Russa 172
IT - Italia 168
UA - Ucraina 165
CN - Cina 157
FI - Finlandia 152
SG - Singapore 148
AT - Austria 144
SE - Svezia 121
DE - Germania 113
CI - Costa d'Avorio 98
BE - Belgio 86
GB - Regno Unito 76
IN - India 26
CA - Canada 19
FR - Francia 16
IR - Iran 11
JP - Giappone 11
BR - Brasile 10
NL - Olanda 10
AU - Australia 9
EU - Europa 8
CL - Cile 6
ES - Italia 6
IL - Israele 6
HK - Hong Kong 4
MX - Messico 4
MY - Malesia 4
NZ - Nuova Zelanda 4
AR - Argentina 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
GR - Grecia 3
LT - Lituania 3
MD - Moldavia 3
RO - Romania 3
VN - Vietnam 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
DK - Danimarca 2
EC - Ecuador 2
PL - Polonia 2
SA - Arabia Saudita 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
CO - Colombia 1
CR - Costa Rica 1
ID - Indonesia 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
TN - Tunisia 1
Totale 4.729
Città #
Dublin 627
Chandler 459
Jacksonville 385
Ann Arbor 163
Vienna 144
Wilmington 126
Helsinki 114
Abidjan 98
Woodbridge 91
New York 90
Brussels 86
Singapore 80
San Mateo 73
Beijing 71
Boardman 66
Princeton 57
Rome 50
Houston 34
Molise 27
Dearborn 24
Los Angeles 23
Ashburn 22
Falls Church 15
Redwood City 15
Dallas 14
London 13
Napoli 13
Nanjing 12
Toronto 11
Hefei 10
Kunming 10
Mountain View 9
Norwalk 9
Auburn Hills 8
Augusta 6
Clearwater 6
Falkenstein 6
Naples 6
Milan 5
San Francisco 5
Shenyang 5
Stockholm 5
Tokyo 5
Hong Kong 4
Leawood 4
Mumbai 4
Ottawa 4
Paris 4
Pune 4
Roseto Degli Abruzzi 4
Sacramento 4
Saint-maur-des-fossés 4
Seattle 4
São Paulo 4
Washington 4
Andover 3
Athens 3
Auckland 3
Baotou 3
Berlin 3
Bologna 3
Caserta 3
Centro 3
Chisinau 3
Gaillimh 3
Haikou 3
Jinan 3
Lappeenranta 3
Madrid 3
Moscow 3
Noicattaro 3
Taiyuan 3
Tappahannock 3
Wuhan 3
Yekaterinburg 3
Zhengzhou 3
Ardabil 2
Birmingham 2
Brixen 2
Cassino 2
Chengdu 2
Dongguan 2
Guangzhou 2
Hebei 2
Kuala Lumpur 2
Melbourne 2
Monmouth Junction 2
Montreal 2
Nanchang 2
Pescara 2
Prague 2
Quito 2
Redmond 2
Riyadh 2
San Vito Chietino 2
Santa Clara 2
Santarcangelo di Romagna 2
St Petersburg 2
Tirana 2
Warsaw 2
Totale 3.257
Nome #
Activation and Desensitization of Trpv1 Channels in Sensory Neurons by the Peroxisome Proliferator-Activated Receptor α Agonist Palmitoylethanolamide 152
Pharmacological Targeting Of Neuronal Kv7.2/3 Channels: A Focus On Chemotypes And Receptor Sites 135
The occurrence of a Kv7.4 potassium channel in neuronal mitochondria 113
Molecular pathophysiology and pharmacology of the voltage-sensing module of neuronal ion channels 112
Activation of Kv7 potassium channels inhibits intracellular Ca2+ increases triggered by TRPV1-mediated pain-inducing stimuli in F11 immortalized sensory neurons 112
Epilepsy-causing mutations in kv7.2 c-terminus affect binding and functional modulation by calmodulin. 112
Early-Onset Epileptic Encephalopathy Caused by Gain-of-Function Mutations in the Voltage Sensor of Kv7.2 and Kv7.3 Potassium Channel Subunits. 101
Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant 101
Expression and function of Kv7.4 channels in Rat cardiac mitochondria: possible targets for cardioprotection 101
Atypical gating of M-type potassium channels conferred by mutations in uncharged residues in the S-4 region of KCNQ2 causing benign familial neonatal convulsions 100
Early-onset epileptic encephalopathy caused by a reduced sensitivity of Kv7.2 potassium channels to phosphatidylinositol 4,5-bisphosphate 98
Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine 98
Effects of natural and synthetic isothiocyanate-based H2S-releasers against chemotherapy-induced neuropathic pain: Role of Kv7 potassium channels 98
Autism and developmental disability caused by KCNQ3 gain-of-function variants 96
Expression, Localization, and Pharmacological Role of K(v)7 Potassium Channels in Skeletal Muscle Proliferation, Differentiation, and Survival after Myotoxic Insults 95
Tryptamine-Based Derivatives as Transient Receptor Potential Melastatin Type 8 (TRPM8) Channel Modulators 95
Epileptic encephalopathy in a patientwith a novel variant in the Kv7.2 S2 transmembrane segment: Clinical, genetic, and functional features 95
β-Adrenergic response is counteracted by extremely-low-frequency pulsed electromagnetic fields in beating cardiomyocytes 94
Characterization of two de novo KCNT1 mutations in children with malignant migrating partial seizures in infancy 94
A novel KCNQ2 K+ channel mutation in benign neonatal convulsions and centrotemporal spikes 93
Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs 91
Decreased subunit stability as a novel mechanism for potassium current impairment by a KCNQ2 C terminus mutation causing benign familial neonatal convulsions 90
Neutralization of a unique, negatively-charged residue in the voltage sensor of K(V)7.2 subunits in a sporadic case of benign familial neonatal seizures 90
Differential Regulation of PI(4,5)P2Sensitivity of Kv7.2 and Kv7.3 Channels by Calmodulin 89
Driving with no brakes: molecular pathophysiology of kv7 potassium channels 87
De novo gain-of-function variants in KCNT2 as a novel cause of developmental and epileptic encephalopathy 85
Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy 85
Kv7.3 Compound Heterozygous Variants in Early Onset Encephalopathy Reveal Additive Contribution of C-Terminal Residues to PIP2-Dependent K+Channel Gating 84
Cardiotoxic effects of antihistamines: From basics to clinics (... and back) 83
Novel KCNQ2 and KCNQ3 mutations in a large cohort of families with benign neonatal epilepsy: first evidence for an altered channel regulation by syntaxin-1A 83
Identification of a Potent Tryptophan-Based TRPM8 Antagonist with in Vivo Analgesic Activity 83
A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation 82
Lysinuric protein intolerance: identification and functional analysis of mutations of the SLC7A7 gene 80
A novel KCNQ3 mutation in familial epilepsy with focal seizures and intellectual disability. 76
Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumors 76
Isoxazole derivatives as potent transient receptor potential melastatin type 8 (TRPM8) agonists. 74
A novel homozygous KCNQ3 loss-of-function variant causes non-syndromic intellectual disability and neonatal-onset pharmacodependent epilepsy 74
Human neoplastic mesothelial cells express voltage-gated sodium channels involved in cell motility 73
The Voltage-Sensing Domain of K(v)7.2 Channels as a Molecular Target for Epilepsy-Causing Mutations and Anticonvulsants 72
Addressing the use of PDIF-CN(2) molecules in the development of n-type organic field-effect transistors for biosensing applications 72
A new Italian FHM2 family: Clinical aspects and functional analysis of the disease-associated mutation 72
Critical role of large-conductance calcium- and voltage-activated potassium channels in leptin-induced neuroprotection of N-methyl-d-aspartate-exposed cortical neurons. 70
Genotype-phenotype correlations in neonatal epilepsies caused by mutations in the voltage sensor of K(v)7.2 potassium channel subunits 69
Functional and biochemical interaction between PPARα receptors and TRPV1 channels: Potential role in PPARα agonists-mediated analgesia. 65
CORRELATING THE CLINICAL AND GENETIC FEATURES OF BENIGN FAMILIAL NEONATAL SEIZURES (BFNS) WITH THE FUNCTIONAL CONSEQUENCES OF THE UNDERLYING MUTATIONS 64
The ever changing moods of calmodulin: how structural plasticity entails transductional adaptability. 63
null 58
Erratum to: Towards the realization of label-free biosensors through impedance spectroscopy integrated with IDES technology 57
Kv7.4 channels regulate potassium permeability in neuronal mitochondria 57
Gating consequences of charge neutralization of arginine residues in the S-4 segment of K(v)7.2, an epilepsy-linked K+ channel subunit 56
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy 56
Functional analysis of novel KCNQ2 and KCNQ3 gene variants found in a large pedigree with benign familial neonatal convulsions (BFNC) 52
Synthesis and Pharmacological Characterization of Conformationally Restricted Retigabine Analogues as Novel Neuronal Kv7 Channel Activators 51
A Novel Kv7.3 Variant in the Voltage-Sensing S4 Segment in a Family With Benign Neonatal Epilepsy: Functional Characterization and in vitro Rescue by β-Hydroxybutyrate 50
Epileptic channelopathies caused by neuronal Kv7 (KCNQ) channel dysfunction 48
KCNQ2 R144 variants cause neurodevelopmental disability with language impairment and autistic features without neonatal seizures through a gain-of-function mechanism 45
Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes 42
Towards the realization of label-free biosensors through impedance spectroscopy integrated with IDES technology 40
Distinct epilepsy phenotypes and response to drugs in KCNA1 gain- and loss-of function variants 39
The long and winding road to personalized medicine in KCNMA1-linked channelopathies revealed by novel variants associated with the Liang-Wang syndrome 38
Gain of function due to increased opening probability by two KCNQ5 pore variants causing developmental and epileptic encephalopathy 37
De novo variants in KCNA3 cause developmental and epileptic encephalopathy 17
Case report: Marked electroclinical improvement by fluoxetine treatment in a patient with KCNT1-related drug-resistant focal epilepsy 15
KCNT2-Related Disorders: Phenotypes, Functional, and Pharmacological Properties 14
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine 13
In Silico Assisted Identification, Synthesis, and In Vitro Pharmacological Characterization of Potent and Selective Blockers of the Epilepsy-Associated KCNT1 Channel 8
Totale 4.920
Categoria #
all - tutte 24.308
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.308


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020445 0 0 0 0 52 32 127 45 91 34 8 56
2020/2021495 20 50 1 72 73 42 69 3 62 10 79 14
2021/2022402 13 65 4 13 42 44 12 35 75 43 26 30
2022/20231.807 225 80 30 181 133 169 11 79 780 59 42 18
2023/2024357 72 40 16 7 8 95 10 17 12 11 10 59
2024/2025560 111 49 147 51 202 0 0 0 0 0 0 0
Totale 4.920